In a significant portfolio shift, Stanley Druckenmiller's Duquesne Family Office completely sold its stake in health insurer Humana (HUM), liquidating 137,500 shares. The position was valued at approximately $23.8 million as of the prior quarter's filing. This exit was part of a broader rebalancing for the firm, which established 48 new positions while exiting 27 during the second quarter.
As with all 13F filings, the disclosure is delayed, meaning these trades occurred between April 1 and June 30, 2026. During this period, Humana reported Q2 earnings that beat analyst estimates but also saw its stock fall as investors weighed concerns over future profit margins and medical costs. The sale reverses a position that had been viewed as a bet on the insurer's recovery in the Medicare Advantage market.